Based on the patient history of chemo-radiotherapy and APSCT, plus the recent findings of neoplastic erythroid proliferation featuring TP53 alteration, the diagnosis of acute erythroid leukemia post-cytostatic therapy was made, in agreement with the fifth edition of the WHO classification. This evidence concerns the gene TP53 and acute erythroid leukemia.